Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butylphthalide in Large-artery Occlusion and Collateral Circulation
NCT04091412Phase 4Unknown
- Sponsor
- The Second Hospital of Hebei Medical University
- Start
- May 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of butylphthalide in cerebral infarction and ischemic stroke, sponsored by The Second Hospital of Hebei Medical University. Primary endpoint: Collateral circulation level at 1 year. Status: unknown.
02
Drugs
butylphthalide
03
Conditions
cerebral infarctionischemic stroke
Beyond the preview
Go deeper on NCT04091412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04091412.